Regulations.gov document
Tab 10 - Herbert L. DuPont et al. - Antibacterial Chemoprophylaxis in the Prevention of…
Supporting & Related Material · FDA-2021-P-0096 · posted Feb 3, 2021
Key facts
| Document ID | FDA-2021-P-0096-0009 |
|---|---|
| Title | Tab 10 - Herbert L. DuPont et al. - Antibacterial Chemoprophylaxis in the Prevention of Traveler’s Diarrhea: Evaluation of Poorly Absorbed Oral Rifaximin RE Citizen Petition from BakerHostetler LLP (on behalf of Salix Pharmaceuticals Inc) |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-P-0096 |
| Posted | Feb 3, 2021 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: